JP2007516701A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007516701A5 JP2007516701A5 JP2006538829A JP2006538829A JP2007516701A5 JP 2007516701 A5 JP2007516701 A5 JP 2007516701A5 JP 2006538829 A JP2006538829 A JP 2006538829A JP 2006538829 A JP2006538829 A JP 2006538829A JP 2007516701 A5 JP2007516701 A5 JP 2007516701A5
- Authority
- JP
- Japan
- Prior art keywords
- saa
- fpr
- hiv
- wkymwvm
- peprotec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- PRQROPMIIGLWRP-BZSNNMDCSA-N chemotactic peptide Chemical compound CSCC[C@H](NC=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PRQROPMIIGLWRP-BZSNNMDCSA-N 0.000 description 2
- 102100021145 fMet-Leu-Phe receptor Human genes 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 102100035875 C-C chemokine receptor type 5 Human genes 0.000 description 1
- 101710149870 C-C chemokine receptor type 5 Proteins 0.000 description 1
- 102100031650 C-X-C chemokine receptor type 4 Human genes 0.000 description 1
- 101710091342 Chemotactic peptide Proteins 0.000 description 1
- 208000031886 HIV Infections Diseases 0.000 description 1
- 101000922348 Homo sapiens C-X-C chemokine receptor type 4 Proteins 0.000 description 1
- 101000818546 Homo sapiens N-formyl peptide receptor 2 Proteins 0.000 description 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
- 102100021126 N-formyl peptide receptor 2 Human genes 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51710403P | 2003-11-05 | 2003-11-05 | |
| US58072004P | 2004-06-21 | 2004-06-21 | |
| PCT/EP2004/013393 WO2005044292A2 (en) | 2003-11-05 | 2004-11-05 | Biomarkers of resistance to hiv-infections in humans and biological applications thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007516701A JP2007516701A (ja) | 2007-06-28 |
| JP2007516701A5 true JP2007516701A5 (enExample) | 2008-01-17 |
Family
ID=34576787
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538829A Pending JP2007516701A (ja) | 2003-11-05 | 2004-11-05 | ヒトのｈｉｖ感染に対して抵抗性のバイオマーカーおよびその生物学的適用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070009926A1 (enExample) |
| EP (1) | EP1748789B1 (enExample) |
| JP (1) | JP2007516701A (enExample) |
| AT (1) | ATE493142T1 (enExample) |
| AU (1) | AU2004287205A1 (enExample) |
| BR (1) | BRPI0416240A (enExample) |
| CA (1) | CA2544972C (enExample) |
| CY (1) | CY1113088T1 (enExample) |
| DE (1) | DE602004030830D1 (enExample) |
| DK (1) | DK1748789T3 (enExample) |
| PL (1) | PL1748789T3 (enExample) |
| PT (1) | PT1748789E (enExample) |
| WO (1) | WO2005044292A2 (enExample) |
| ZA (1) | ZA200604550B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361968B (zh) | 2007-08-06 | 2011-08-03 | 健能隆医药技术（上海）有限公司 | 白介素-22在治疗脂肪肝中的应用 |
| US10545149B2 (en) * | 2008-10-06 | 2020-01-28 | Morehouse School Of Medicine | Detection of HIV-related proteins in urine |
| GB201002409D0 (en) * | 2010-02-12 | 2010-03-31 | Univ Nottingham | Methods |
| JP2013540757A (ja) | 2010-09-24 | 2013-11-07 | ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド | カプセル化された作用物質の放出を制御する能力を有するナノ構造ゲル |
| EA035645B1 (ru) | 2013-03-15 | 2020-07-21 | Дженентек, Инк. | ПОЛИПЕПТИДЫ IL-22, ХИМЕРНЫЕ БЕЛКИ IL-22 Fc И ИХ ПРИМЕНЕНИЕ |
| US10646548B2 (en) * | 2013-10-08 | 2020-05-12 | Georgia State University Research Foundation, Inc. | Compositions including IL-18 and IL-22 and their use in anti-viral therapies |
| CN104623637A (zh) | 2013-11-07 | 2015-05-20 | 健能隆医药技术（上海）有限公司 | Il-22二聚体在制备静脉注射药物中的应用 |
| EP3442562B1 (en) | 2016-04-15 | 2022-09-21 | Evive Biotechnology (Shanghai) Ltd | An il-22 dimer for use in treating necrotizing enterocolitis |
| US11839605B2 (en) * | 2018-10-11 | 2023-12-12 | Alivio Therapeutics, Inc. | Non-injectable hydrogel formulations for smart release |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030003545A1 (en) * | 1998-05-29 | 2003-01-02 | Reinhard Ebner | Interleukins-21 and 22 |
| US20010023070A1 (en) * | 1998-05-29 | 2001-09-20 | Reinhard Ebner | Interleukins-21 and 22 |
| US6939545B2 (en) * | 1999-04-28 | 2005-09-06 | Genetics Institute, Llc | Composition and method for treating inflammatory disorders |
| US20030170823A1 (en) * | 1999-12-23 | 2003-09-11 | Presnell Scott R. | Novel cytokine ZCYTO18 |
| GB0024442D0 (en) * | 2000-10-05 | 2000-11-22 | Isis Innovation | Genetic factors affecting the outcome of viral infections |
| WO2002060468A2 (en) * | 2001-01-30 | 2002-08-08 | University Of Iowa Research Foundation | Antiviral activities of primate theta defensins and mammalian cathelicidins |
-
2004
- 2004-11-05 JP JP2006538829A patent/JP2007516701A/ja active Pending
- 2004-11-05 CA CA2544972A patent/CA2544972C/en not_active Expired - Fee Related
- 2004-11-05 PL PL04803279T patent/PL1748789T3/pl unknown
- 2004-11-05 AT AT04803279T patent/ATE493142T1/de active
- 2004-11-05 BR BRPI0416240-4A patent/BRPI0416240A/pt not_active Application Discontinuation
- 2004-11-05 DK DK04803279.1T patent/DK1748789T3/da active
- 2004-11-05 EP EP04803279A patent/EP1748789B1/en not_active Expired - Lifetime
- 2004-11-05 PT PT04803279T patent/PT1748789E/pt unknown
- 2004-11-05 WO PCT/EP2004/013393 patent/WO2005044292A2/en not_active Ceased
- 2004-11-05 DE DE602004030830T patent/DE602004030830D1/de not_active Expired - Lifetime
- 2004-11-05 AU AU2004287205A patent/AU2004287205A1/en not_active Abandoned
-
2006
- 2006-05-05 US US11/381,811 patent/US20070009926A1/en not_active Abandoned
- 2006-06-02 ZA ZA2006/04550A patent/ZA200604550B/en unknown
-
2011
- 2011-03-28 CY CY20111100330T patent/CY1113088T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115698012A (zh) | 环修饰的脯氨酸短肽化合物及其应用 | |
| CY1118037T1 (el) | Αντισωματα εναντι του αβητα και h χρηση τους | |
| EP3263589A3 (en) | Peptide sequences and compositions | |
| MXPA06003474A (es) | Agonistas de receptores de melanocortina. | |
| JP2009537143A5 (enExample) | ||
| JP2005501532A5 (enExample) | ||
| EA200700210A1 (ru) | ВАРИАНТЫ ОБЛАСТИ Fc | |
| JP2010065037A5 (enExample) | ||
| ATE376559T1 (de) | Methoden der verhinderung und behandlung der alzheimer'schen krankheit | |
| JP2006506942A5 (enExample) | ||
| WO2007048857A8 (es) | USO DE PÉPTIDOS INHIBIDORES DE TGF- βl EN LA PREPARACIÓN DE UN AGENTE MODULADOR DE LA RESPUESTA INMUNE | |
| JP2007516701A5 (enExample) | ||
| JP2019533722A5 (enExample) | ||
| JP2008539252A5 (enExample) | ||
| JP2019214579A5 (enExample) | ||
| WO2005061532A8 (es) | Composiciones y procedimientos para detectar infección patógena | |
| MY140306A (en) | Corticotropin releasing factor receptor 2 agonists | |
| CN110799522A (zh) | 用于治疗、改善或预防脑出血的肽及其用途 | |
| JP2007510403A5 (enExample) | ||
| JP2008521795A5 (enExample) | ||
| ES2585185T3 (es) | Polipéptidos quiméricos y sus aplicaciones terapéuticas contra una infección por Flaviviridae | |
| WO2007019865A3 (en) | Therapy with cd4 binding peptides and radiation | |
| JP2019038772A5 (enExample) | ||
| DE602004028266D1 (de) | Angiogene peptide und ihre verwendungen | |
| JP2006523185A5 (enExample) |